Candeur

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Candeur

What is Candeur? (Fluconazole)

Property Description
Active ingredient Fluconazole
Form Capsules, Tablets, Oral Suspension, Sterile Solution for Injection
Pharmacological class Systemic Triazole Antifungal Agent
Common use Resolution of fungal and yeast infections (General purpose)
Origin Synthetic triazole derivative

What Type of Medicine is Candeur and What is its Composition?

Candeur is the trade name for a synthetic prescription medication containing the active compound Fluconazole, chemically classified as a Systemic Triazole Antifungal Agent. It is fundamentally a monotherapy product, containing this single ingredient designed to treat infections throughout the body. The synthetic origin of Fluconazole provides it with key pharmacological advantages, including high oral bioavailability and broad distribution into various body tissues, which are necessary for combating systemic or deep-seated fungal infections. Fluconazole is classified as an azole antifungal agent intended for systemic use.


Forms, Administration Routes, and General Therapeutic Purpose

Candeur is available in several high-level pharmaceutical preparations to ensure therapeutic flexibility. These forms include capsules, tablets, an oral suspension (liquid), and a sterile solution for injection. Its primary route of administration is Oral, though the injection form is used for Intravenous (IV) delivery in clinical settings, particularly for severe infections. The general therapeutic purpose of Candeur is to control and resolve infections caused by various types of fungi and yeast, primarily targeting species within the Candida genus. Fluconazole is clinically recognized for its effectiveness in treating mucosal and systemic candidiasis.


High-Level Mechanism: How Fluconazole Disrupts Fungal Cells

Fluconazole works by specifically disrupting the structural integrity of the fungal cells responsible for the infection. It achieves this by acting as a highly selective inhibitor of a key fungal enzyme, which prevents the synthesis of ergosterol, a vital component of the fungal cell membrane. This mechanism ultimately leads to the destabilization and compromised function of the fungal cell wall, resulting in fungistatic activity that arrests the organism's growth, which is essential for clearing the fungal presence from the affected tissues.

Regulatory References

  1. NIH, MedlinePlus

What side effects are possible with Candeur?

Possible Side Effects and Safety Information for Candeur

This section outlines the officially documented adverse reactions and safety information for Candeur, strictly as defined in government regulatory documents from agencies like the FDA and EMA.

Adverse Reaction Scope

The full safety profile is classified according to medical terminology and organized by the body system affected (System-Organ Class or SOC) and how frequently each reaction occurred in clinical trials.

Classification Type Details
Adverse Reaction Frequency Side effects are grouped by their incidence rate: Very Common (1/10); Common (1/100 to < 1/10); Uncommon (1/1,000 to < 1/100); Rare (1/10,000 to < 1/1,000); Not Known (cannot be estimated).
System-Organ Classes Documented adverse reactions affect various systems, commonly including Gastrointestinal Disorders, Nervous System Disorders, and Skin and Subcutaneous Tissue Disorders.
Serious Adverse Reactions The regulatory label identifies specific rare but critical events, such as Anaphylaxis and Severe Hepatotoxicity, which are documented as having serious clinical implications.

Safety Restrictions and Specific Populations

Official labeling includes constraints and specific warnings for certain groups. Safety-related restrictions mandate the drug is Contraindicated in patients with known hypersensitivity to the active substance. Population-Specific Safety Information addresses risks for groups such as Older Adults and patients with Severe Hepatic or Renal Impairment, sometimes requiring dose adjustments or heightened monitoring as specified in the official documentation.

The label also details Safety Monitoring Requirements, often mandating baseline and periodic laboratory evaluations (e.g., liver function tests) to observe for known potential high-level consequences like electrolyte imbalances.

Connection to the Overall Safety Profile

The use of mandatory frequency bands and System-Organ Class groupings formally structures the drug's risk profile, differentiating between probable and rare events. This regulatory framework provides a standardized, objective overview of all documented side effects and mandatory safety constraints, defining the boundaries for its official safe use.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documents for Candeur (Fluconazole) outline specific manifestations and mandatory actions in the event of an overdose. Overdose has been reported to be accompanied by specific central nervous system (CNS) effects, including the presence of hallucinations and paranoid behavior.

Required Emergency Actions

Seeking immediate medical attention is required for any suspected overdose. Government guidance explicitly mandates that individuals contact emergency services if severe manifestations occur, such as collapse, trouble breathing, or inability to be awakened. These events are classified as severe situations requiring urgent medical care.

Official Overdose Management Procedural Measures
Symptomatic and supportive treatment Gastric lavage (if clinically indicated)
No specific antidote is known Hemodialysis (reduces plasma levels by approx. 50% in a 3-hour session)

The standard management plan, according to regulatory information, focuses on supportive measures since no specific antidote is available. Hemodialysis is a documented procedural option that can be utilized to aid the clearance of the drug from the plasma. No population-specific overdose considerations for pediatric or elderly patients are explicitly listed in the official overdose sections.

This profile defines the official emergency response based on documented CNS risks and the need for immediate professional intervention to manage the overdose using defined supportive and procedural methods.

Therapeutic Uses of Candeur

What Candeur Treats: Main Uses and Benefits

Candeur is commonly used in clinical settings that involve acute or unstable symptom patterns caused by fungal and yeast infections. Its primary therapeutic domains are the managing and addressing of conditions presenting with acute episodes of fungal overgrowth, including oral thrush, esophageal candidiasis, vulvovaginal yeast infections, systemic candidiasis, and Cryptococcal Meningitis.

The medication helps address symptom clusters that may become intense or disruptive, such as itching, burning, soreness, or severe headache. This is relevant when supportive symptom management is appropriate, particularly in high-risk patient groups like those undergoing bone marrow transplantation or those with severely weakened immune systems. The application in these scenarios helps maintain a sense of stability when symptoms are more noticeable.

“This medication is commonly used across conditions where symptoms create noticeable physiological strain and interfere with daily comfort.”

It provides support that helps ease the overall symptom burden, contributing to improved comfort during periods of heightened symptoms associated with systemic imbalance or localized inflammatory states.


Quick Fact: Applied for Localized Fungal Discomfort
Candeur is commonly used to help manage symptoms related to inflammatory or irritative states on mucous membranes, contributing to improved comfort and assisting with maintaining functional stability during symptomatic periods.

Regulatory References

  1. NIH DailyMed label

Eligibility and Restrictions for Use

Official Eligibility Profile

Candeur (Fluconazole) eligibility is defined by regulatory guidelines based on patient status, co-administered medicines, and organ function. The medication is established for use in adults, adolescents, and children, including term and preterm neonates, for approved systemic and mucosal fungal infections. However, the regulatory label notes that use for genital candidiasis is not established in the pediatric population.

Contraindications (Absolute Non-Eligibility):

  • Hypersensitivity: Patients with known allergy to fluconazole or other azole antifungals must not use the medicine.
  • Drug Co-administration: Use is prohibited when co-administered with certain medications known to prolong the QT interval and metabolized via the CYP3A4 enzyme (e.g., cisapride, pimozide, erythromycin).
  • Hereditary Disorders: Patients with rare metabolic disorders like galactose intolerance or sucrase-isomaltase deficiency are restricted from using specific Candeur formulations.

Conditions Requiring Caution or Restriction:

  • Renal Impairment: Patients with impaired kidney function require a reduced dose for multi-dose therapy.
  • Hepatic Impairment: Use requires caution in patients with liver dysfunction.
  • Pregnancy/Lactation: Use during pregnancy is generally not recommended unless the infection is life-threatening. Breastfeeding is not recommended after high-dose or repeated use.

What should I know about interactions with other medicines?

Candeur is an immunosuppressive medication that can interact with a wide variety of other medicines and products, potentially leading to serious side effects or a decrease in its effectiveness. These interactions are often due to Candeur's metabolism being influenced by the body's enzyme systems. Always inform your healthcare provider about all prescription drugs, over-the-counter medicines, and herbal supplements you are taking.

Medications that Increase Candeur Levels (Risk of Toxicity)

Co-administration with certain drugs can slow the breakdown of Candeur, causing its levels in the blood to rise, which increases the risk of serious toxicities, particularly to the kidneys and nervous system. Examples include:

  • Certain Antifungals: Such as ketoconazole, fluconazole, or voriconazole.
  • Certain Antibiotics: Including erythromycin and clarithromycin (macrolides).
  • Certain Calcium Channel Blockers: Such as diltiazem and verapamil.

Medications that Decrease Candeur Levels (Risk of Organ Rejection)

Other medications can speed up the removal of Candeur from the body, leading to lower blood levels and potentially increasing the risk of organ rejection (in transplant patients) or therapeutic failure. Examples include:

  • Certain Anticonvulsants: Such as phenytoin or carbamazepine.
  • Rifampin: An antibiotic used to treat tuberculosis.
  • St. John’s Wort: An herbal supplement used for mood disorders.

Medications that Increase the Risk of Organ Toxicity

Combining Candeur with other drugs that are also toxic to the kidneys (nephrotoxic) may significantly increase the risk of kidney damage. This applies to:

  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Such as ibuprofen or naproxen.
  • Aminoglycoside Antibiotics: Such as gentamicin.

Food and Beverage Interactions

  • Grapefruit and Grapefruit Juice: Consumption should be avoided as they can significantly increase Candeur blood levels and the risk of toxicity.
  • Alcohol: Should be used with caution due to potential additive effects on the liver and kidneys.

Mechanism of Action

The mechanism of action for Candeur (Fluconazole) is characterized by highly selective interference with the invading fungal organism’s cellular structure, resulting in growth inhibition.

Targeted Inhibition of Fungal 14alpha-Demethylase

The molecule functions as a selective inhibitor of the fungal enzyme 14alpha-lanosterol demethylase (CYP51). This enzyme is essential for the cell's structural integrity. Fluconazole's triazole nitrogen coordinates with the heme iron at the active site, initiating a cascade of biochemical changes.

Disruption of Ergosterol Biosynthesis

By blocking the enzyme, Fluconazole completely interrupts the ergosterol biosynthesis pathway, preventing the creation of ergosterol, a vital component of the fungal cell membrane. This simultaneous action leads to the accumulation of toxic methylated sterol precursors within the cell.

Mechanism-Induced Fungal Growth Inhibition

The combined effects of ergosterol depletion and intermediary sterol accumulation compromise the fungal cell membrane, resulting in increased permeability and functional failure. This sequence produces a fungistatic effect, characterized by the inhibition of fungal replication.

Biological Constraints on Mechanism Effectiveness

Efficacy is constrained by intrinsic fungal factors, including active drug expulsion via efflux pumps and genetic mutations in the 14alpha-demethylase target enzyme. These factors limit the drug's availability to bind to its target.

Dosage and Administration Information

The administration of Candeur (Fluconazole) must strictly follow the instructions outlined in the official regulatory labeling. The official daily dose is equivalent for both the oral (capsules, tablets, or suspension) and intravenous (IV) infusion routes.

Dosing and Frequency

For multiple-dose regimens, a loading dose—typically twice the maintenance dose—is administered on Day 1 to achieve steady-state plasma concentrations more rapidly. The standard dosing frequency thereafter is once daily. Treatment duration is dependent on the infection but is often specified as a minimum course (e.g., at least two weeks for oropharyngeal infections) or indefinitely for maintenance therapy in specific patient populations.

Dosing Constraint Official Rule (Multi-Dose Regimens)
Renal Impairment ( CrCl le 50 mL/ min) Reduce subsequent daily dose to 50% after the initial loading dose.
Hemodialysis Patients Administer 100% of the recommended dose after each dialysis session.
Pediatrics (Neonates) Dosing is calculated by weight ( mg/ kg), and the interval is extended in the first few weeks of life (e.g., every 72 hours for the first two weeks).

Administration Conditions

Oral forms may be taken with or without food. If the oral suspension is used, official documents specify that the bottle must be shaken well before measuring, and a calibrated device should be used for accurate dosing. The intravenous solution must be administered via infusion at a controlled rate, not exceeding 10 mL/ minute (or 200 mg/ hour), as detailed in the official prescribing information. The daily dosage does not require adjustment when a patient switches from IV to oral administration, or vice versa.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Candeur (Fluconazole)

This section summarizes the official clinical research, such as large-scale randomized controlled trials (RCTs) and systematic reviews, that scientific bodies rely on to understand the evidence base concerning fungal infections. The findings described relate to patterns observed in study groups.


Evidence Supporting Core Antifungal Uses (Localized Infections)

The research landscape includes short-term RCTs for oral and esophageal candidiasis and vulvovaginal candidiasis. Studies primarily measured clinical resolution (evaluating changes in symptoms) and microbiological cure. The research so far indicates patterns related to the disappearance of symptoms and fungal clearance in observed populations.

However, research highlights that the optimal strategy for relapse prevention is not fully established in all high-risk groups. Studies have also been applied in research exploring the development of azole resistance, which may be observed over time.


Evidence for Management of Systemic and Severe Fungal Infections

The evidence concerning systemic infections, such as candidemia, involved large-scale RCTs. These studies was studied for outcomes related to fungal-free survival and overall mortality. The research for its use in the subsequent consolidation and maintenance phases of cryptococcal meningitis focused on relapse prevention.

What remains uncertain is the data availability for all fungal species; evidence is limited regarding its evaluation against less-susceptible species such as C. glabrata. Also, data are still emerging regarding whether fungal clearance consistently translates into a measured reduction in overall mortality in all complex subgroups.


Research on Prevention (Prophylaxis) and Limitations

Candeur was studied for the prevention of invasive fungal infections (IFI) in high-risk patients, including those undergoing transplantation. Findings describe patterns related to a reported lower incidence of Candida infections when compared to placebo. However, research highlights its limited activity against filamentous fungi (molds).

Key research limitations include the fact that the results apply only to the populations studied, and there is limited information for long-term outcomes that track patient status far beyond the immediate post-treatment period.

Key Studies & References

  1. Label: FLUCONAZOLE tablet - DailyMed (NIH)
  2. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America (IDSA)

Frequently Asked Questions (FAQ)

Common questions about Candeur (FAQ)


Q: Can Candeur be used for long-term or chronic conditions?

Official documents indicate that Candeur is used for long-term suppressive treatment for certain serious fungal infections, such as cryptococcal meningitis relapse prevention.

The length of time a person uses the medicine is always determined by the specific infection and the patient's condition.


Q: Does Candeur work to cure a condition or primarily to manage symptoms?

Candeur works primarily by having a fungistatic effect, which means it stops the fungal organism from growing and reproducing.

Treatment continues until official tests show the active infection has cleared, known as microbiological cure, or symptoms have resolved.


Q: What are the most common side effects listed for Candeur?

According to the official product information, the most common side effects are those classified as very common, meaning they affect 1 in 10 patients or more.

These typically include headache, nausea, abdominal pain, and diarrhea.


Q: What are the official signs of a serious or severe reaction to Candeur?

Official safety information states that rare but severe reactions can occur. These can manifest as signs of a severe skin condition, such as fever with blistering or peeling skin, or signs of liver problems, like yellowing of the skin or eyes (jaundice).

Seizures are also listed as a potential serious reaction.


Q: Are the side effects of Candeur different in older adults compared to younger patients?

Official studies note that the rate at which the body processes the drug (pharmacokinetics) may be slower in older adults compared to younger people.

For older patients with kidney impairment, official documents indicate that a dose adjustment may be required.


Q: Can taking Candeur cause stomach issues like nausea, vomiting, or diarrhea?

Yes, the official adverse reaction data lists stomach issues among the most frequently reported problems.

Nausea, vomiting, abdominal pain, and diarrhea are all classified as very common side effects, meaning they are observed in a high percentage of patients.


Q: Are there any over-the-counter (OTC) cold or pain medicines that interact with Candeur?

Official regulatory documents specifically warn about the co-administration of Candeur with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), which are common pain relievers.

The official warnings advise consulting a healthcare provider before combining Candeur with any OTC medicines.


Q: What types of blood pressure or heart medications should be checked for interactions with Candeur?

Regulatory information states that Candeur use is prohibited alongside certain medicines that are known to prolong the QT interval, a measurement of heart rhythm.

Other drugs metabolized via the CYP3A4 enzyme should also be reviewed for potential interactions that could affect the heart.


Q: What is the typical recommended duration for treatment with Candeur?

The length of treatment for Candeur is highly variable and depends on the specific fungal infection being addressed.

Treatment can range from a single dose for localized issues to courses lasting a minimum of 10 to 12 weeks or longer for more severe, systemic infections.


Q: Where can I find the official FDA or EMA package insert for Candeur?

Official prescribing information, including the detailed label, package insert, and data sheets, is published on regulatory government websites.

You can typically find these official documents on sites maintained by the FDA (DailyMed) or the EMA (Summary of Product Characteristics).


Q: What is the name of the company that manufactures Candeur?

The official product information and labeling for the brand name product, Candeur, cite the original manufacturer as Pfizer.


Q: Why are there different dosages of Candeur available?

The official dosage of Candeur is determined by several factors outlined in the prescribing information.

These include the nature and severity of the fungal infection, the patient's body weight (in pediatric cases), and whether a loading dose is required to achieve therapeutic blood levels quickly.


Q: Is a generic version of Candeur currently available?

Yes, the active ingredient in Candeur, which is fluconazole, is widely available and prescribed as a generic drug.


Q: How long do the initial side effects of Candeur typically last?

The official safety profile indicates that many side effects are temporary in nature.

If initial side effects occur, official information suggests they may be temporary, potentially resolving within a few days or weeks.


Q: Is weight gain or weight loss listed as a possible side effect of Candeur?

According to the official product information, loss of appetite (anorexia) and subsequent weight loss are listed among the potential side effects.


Q: Does Candeur cause drowsiness or affect alertness for tasks like driving?

The official warnings state that Candeur may cause dizziness or, in rare cases, seizures.

Due to these potential effects on the nervous system, caution is generally indicated when performing tasks that require full alertness, such as driving or operating machinery.


Q: Does Candeur affect the effectiveness of birth control pills?

Studies examining the co-administration of Candeur with certain oral contraceptives show only small and inconsistent changes in the blood levels of the birth control hormones.


Q: How quickly is Candeur expected to start having an effect?

The expected time for Candeur to start working varies based on the infection type.

For localized issues, symptom relief may begin as soon as one day. For more severe or systemic infections, it may take one to two weeks for the drug to reach its full therapeutic effect.


Q: How long does Candeur stay in your system after the last dose?

The time it takes for Candeur to be eliminated from the body is measured by its half-life, which is approximately 30 hours.

Based on this pharmacokinetic data, the drug is typically expected to be completely cleared from the system after about six days following the final dose.


Q: Why do official documents state Candeur might take weeks to show full therapeutic effect?

While the drug reaches its consistent level in the blood (steady-state) within 5 to 10 days, the overall time to achieve the full desired outcome can take weeks.

This is usually due to the required time for the immune system to fully resolve the underlying severe fungal infection itself.


Q: Does having diabetes affect who can or cannot use Candeur?

Official drug interaction data indicates that Candeur can interact with certain oral diabetes medications (hypoglycemics), potentially increasing the risk of adverse effects from the diabetes drug.

Official warnings indicate that professional monitoring of blood sugar may be necessary when these medications are used together.


Q: Is Candeur a safe option for people who have a history of seizures?

Seizures are listed as a rare potential adverse reaction in the official safety profile.

Patients with a pre-existing history of seizure disorders should have their status recorded by a healthcare provider, as special caution and professional monitoring may be indicated.


Q: Can Candeur make people feel depressed or anxious?

Official documentation notes that mental depression and other mood changes are listed as potential, though less common, side effects.

This information comes from reports during clinical trials or post-marketing surveillance.


Q: Is it normal to have less appetite when starting Candeur?

Yes, loss of appetite (anorexia) is listed in the official safety profile as a potential side effect of using Candeur.


Q: What is the half-life of Candeur in the body?

According to pharmacokinetic data in the official prescribing information, the terminal plasma elimination half-life of Candeur is approximately 30 hours.

This is the time it takes for the concentration of the drug in the body to be reduced by half.

How should Candeur be stored and disposed of?

The official requirements for storing and disposing of Candeur (fluconazole) vary based on the specific formulation.

Storage Conditions and Stability

Formulation Required Storage Condition
Tablets / Dry Powder Store below 86 F (30 C).
Reconstituted Suspension Store between 41 F and 86 F (5 C and 30 C).

All forms must be protected from freezing. The tablets and dry powder must be kept away from light and moisture. The medication must remain in its original container, tightly closed, and stored out of the sight and reach of children. The liquid oral suspension must be discarded after 14 days of mixing, even if stored within the correct temperature range.

Disposal Instructions

Unused or expired Candeur must be safely thrown away according to established federal and local guidelines for medicine disposal. Do not dispose of the medication by flushing it down a toilet or pouring it down a drain unless specifically instructed to do so by an official government program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Candeur found in:

A-Z Index: